JNJ vs ABBV: Which Is the Better Dividend Stock?
A head-to-head dividend comparison of Johnson & Johnson and AbbVie Inc. — yield, payout safety, growth and total return. ABBV wins more categories overall.
| Metric | JNJ | ABBV |
|---|---|---|
| Forward yield | 2.35% | 3.08% |
| Annual dividend | $5.36 | $6.92 |
| Payout ratio | 60% | 326% |
| Years of growth | 55 yr | 12 yr |
| 5-yr dividend growth | 5.2% | 6.8% |
| 5-yr total return | 41% | 102% |
| Dividend safety score | 89 (A) | 81 (A) |
| Frequency | quarterly | quarterly |
| Market cap | $549.3B | $397.4B |
| P/E ratio | 26.5 | 109.7 |
Higher yield
ABBV
3.08%
Safer dividend
JNJ
Grade A
Faster growth
ABBV
6.8%
JNJ vs ABBV — FAQ
Data refreshes daily · for informational purposes only, not investment advice.